⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29284410 | 0.97 | — | — | |
| SCHEMBL29284544 | 0.89 | TOP1 (0.34) | — | |
| SCHEMBL29284280 | 0.87 | TOP1 (0.38) | — | |
| SCHEMBL29284495 | 0.83 | ALDH1A1 (0.39) | — | |
| SCHEMBL29284283 | 0.83 | TOP1 (0.34) | — | |
| SCHEMBL3101667 | 0.82 | — | — | |
| SCHEMBL242590 | 0.82 | — | — | |
| SCHEMBL3632234 | 0.82 | — | — | |
| SCHEMBL147635 | 0.81 | — | — | |
| SCHEMBL291790 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119588-A | Precursors for phenolic aromatic compounds | 奇华顿股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2023190410-A1 | COMPOUND, POLYMERIZABLE COMPOSITION, CURED PRODUCT, COLOR FILTER, PARTITION WALL AND IMAGE DISPLAY DEVICE | 三菱ケミカル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20230042328-A1 | IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS | BASF SE (DE) | 2023-02-09 | — | — | US | disclosed |
| CN-109422749-B | Pyrimidinedione derivative for inhibiting monocarboxylic acid transporter | 重庆医药工业研究院有限责任公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-109715605-B | Process for preparing carotenoid monoesters | 巴斯夫欧洲公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-109320509-B | FXR receptor agonists | 轩竹生物科技股份有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-108602811-B | FXR receptor agonists | 轩竹生物科技有限公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-108558842-B | Pyrimidine derivative anaplastic lymphoma kinase inhibitor | 山东轩竹医药科技有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-107108586-B | Polycyclic anaplastic lymphoma kinase inhibitors | 山东轩竹医药科技有限公司 | 2020-07-10 | — | — | CN | disclosed |
| CN-105524045-B | Tetracyclic anaplastic lymphoma kinase inhibitors | 山东轩竹医药科技有限公司 | 2020-04-10 | — | — | CN | disclosed |
| EP-0719258-A1 | CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-07-03 | — | — | EP | disclosed |
| WO-1996002508-A1 | CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-01 | — | — | WO | disclosed |
| CN-1114834-A | antidiabetic agent | OTSUKA PHARMA CO LTD (JP) | 1996-01-10 | — | — | CN | disclosed |
| US-5306719-A | Cardiotonic agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0255134-B1 | CARBOSTYRIL DERIVATIVES AND SALTS THEREOF, PROCESS FOR PREPARING THEM, AND CARDIOTONIC COMPOSITION CONTAINING SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-03 | — | — | EP | disclosed |
| US-5071856-A | CARBOSTYRIL DERIVATIVES AND SALTS THEREOF | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-10 | — | — | US | disclosed |
| US-4886809-A | CARDIOTONIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| US-4845100-A | WITH HYPOTENSIVE AND ANTIINFLAMMATORY ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| EP-0255134-A2 | Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-02-03 | — | — | EP | disclosed |
| EP-0202760-A2 | Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-11-26 | — | — | EP | disclosed |